Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

Fox, Caroline S, Matsushita, Kunihiro, Woodward, Mark, Bilo, Henk JG, Chalmers, John, Heerspink, Hiddo J Lambers, Lee, Brian J, Perkins, Robert M +9 more·2012·The Lancet

Cited by (1,001)

Items 701–800 of 1,001

  1. miR‐154‐5p Affects the TGF β 1/Smad3 Pathway on the Fibrosis of Diabetic Kidney Disease via Binding E3 Ubiquitin Ligase Smurf1
    Che Bian, Zhi‐Lin Luan, Haibo Zhang, Ruijing Zhang, Jing Gao, Yuxia Wang, Jia Li, Huiwen Ren · 2022 · Oxidative Medicine and Cellular Longevity
  2. Prognostic significance of albuminuria in elderly of various ages with diabetes
    Subin Hwang, Kyungho Lee, Jeeeun Park, Do Hee Kim, Junseok Jeon, Hye Ryoun Jang, Kyu Yeon Hur, Jae Hyeon Kim, Wooseong Huh, Yoon-Goo Kim et al. · 2023 · Scientific Reports
  3. Obstructive sleep apnea, coronary calcification and arterial stiffness in patients with diabetic kidney disease
    Sebastian Nielsen, Jakob Tobias Nyvad, Kent Lodberg Christensen, Per Løgstrup Poulsen, Esben Laugesen, Erik Lerkevang Grove, Niels Henrik Buus · 2023 · Atherosclerosis
  4. Avosentan is protective in hypertensive nephropathy at doses not causing fluid retention
    Ovidiu Constantin Baltatu, Christian E. Zaugg, Christoph Schumacher, Pat Louie, Luciana Aparecida Campos, Michael Bäder · 2013 · Pharmacological Research
  5. Prevalência da microalbuminúria em doentes hipertensos e/ou diabéticos tipo 2 nos Cuidados de Saúde Primários em Portugal: Estudo RACE (micRoAlbumin sCreening survEy)
    Pedro Marques da Silva, Davide Maurício Carvalho, José Nazaré, Luís Martins, Carlos Aguíar, Maria Conceição Manso, Teresa Carqueja, Jorge Junqueira Polónia · 2015 · Revista Portuguesa de Cardiologia
  6. All-cause mortality and estimated renal function in type 2 diabetes mellitus outpatients: Is there a relationship with the equation used?
    Fabio Fabbian, Alfredo De Giorgi, Marcello Monesi, Marco Pala, Ruana Tiseo, Elisa Misurati, Claudia Parisi, Riccardo Volpi, Roberto Graziani, Dimitri P. Mikhailidis et al. · 2014 · Diabetes and Vascular Disease Research
  7. Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease
    Jean Kaboré, Marie Metzger, Catherine Helmer, Claudine Berr, Christophe Tzourio, Tilman Bernhard Drüeke, Ziad A. Massy, Bénédicte Stengel · 2016 · Kidney International Reports
  8. Glycaemic control and excess risk of major coronary events in patients with type 2 diabetes: a population-based study
    Mauro Tancredi, Annika Rosengren, Ann‐Marie Svensson, Aldina Pivodic, Soffia Guðbjörnsdóttir, Hans Wedel, Marcus Lind · 2019 · Open Heart
  9. Outcomes for Inappropriate Renal Dose Adjustment of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus: Population-Based Study
    Sangmo Hong, Kyungdo Han, Cheol‐Young Park · 2019 · Mayo Clinic Proceedings
  10. How to Manage Hypertension in People With Diabetes
    Waleed Ali, George L. Bakris · 2020 · American Journal of Hypertension
  11. Invasive Management of Coronary Artery Disease in Advanced Renal Disease
    Keyvan Karimi Galougahi, S. Chadban, R. Mehran, S. Bangalore, G. Chertow, Z. Ali · 2021 · Kidney International Reports
  12. Predictive Effect of Renal Function on Clinical Outcomes in Older Adults With Acute Myocardial Infarction: Results From an Observational Cohort Study in China
    Hui Gao, Hui Peng, Aidong Shen, Hui Chen, Hongwei Li · 2021 · Frontiers in Cardiovascular Medicine
  13. Cardiorenal syndrome: classification, pathophysiology, diagnosis and management. Literature review
    Jonathan Samuel Chavez-Iñiguez, Sergio J. Sánchez-Villaseca, Luz A. García-Macías · 2022 · Archivos de cardiolog�a de M�xico (English ed Internet)
  14. Plasma pro-inflammatory cytokines, IgM-uria and cardiovascular events in patients with chest pain: A comparative study
    Rafid Tofik, Per Swärd, Ulf E. G. Ekelund, André Struglics, Ole Torffvit, Bengt Rippe, Omran Bakoush · 2015 · Scandinavian Journal of Clinical and Laboratory Investigation
  15. Estimated Glomerular Filtration Rate Decline Is a Better Risk Factor for Outcomes of Systemic Disease-Related Nephropathy than for Outcomes of Primary Renal Diseases
    Shuo‐Chun Weng, Der‐Cherng Tarng, Chyong‐Mei Chen, Chi‐Hung Cheng, Ming‐Ju Wu, Cheng‐Hsu Chen, Tung‐Min Yu, Kuo‐Hsiung Shu, on behalf of the CKDBHPDH investigators · 2014 · PLoS ONE
  16. Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes: findings from the improving Care for Cardiovascular Disease in China - Acute Coronary Syndrome (CCC-ACS) project
    Nan Ye, Lijiao Yang, Guoqin Wang, Weijing Bian, Fengbo Xu, Changsheng Ma, Dong Hui Zhao, Jing Liu, Yongchen Hao, Jun Liu et al. · 2020 · BMC Cardiovascular Disorders
  17. Screening, prevalence, and burden of chronic kidney disease in people with type 2 diabetes managed by endocrinologists: A nationwide cross-sectional study
    José Ignacio Martínez‐Montoro, José Juan Aparicio-Sánchez, Belén Pimentel, Mónica Juárez-Campo, María Luisa Alamillo, José Carlos Fernández‐García · 2025 · Diabetes Research and Clinical Practice
  18. Cardiovascular events and mortality in chronic kidney disease in primary care patients with previous type 2 diabetes and/or hypertension. A population-based epidemiological study (KIDNEES)
    Oriol Cunillera, David Vizcaya, M. Jesús Cerain-Herrero, Neus Gil-Terrón, Sílvia Cobo Guerrero, Betlem Salvador-González · 2022 · BMC Nephrology
  19. Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk
    Joshua J. Neumiller, Jeph S. Herrin, KAVYA SINDHU SWARNA, Eric C. Polley, Rodolfo Javier Galindo, Guillermo E. Umpierrez, Yihong Deng, Joseph S. Ross, Mindy M. Mickelson, Rozalina G. McCoy · 2024 · Clinical Journal of the American Society of Nephrology
  20. Blood pressure targets for hypertension in people with chronic renal disease
    Juan Erviti, Luis Carlos Saiz, Leire Leache, José Ignacio Pijoán, Miguel Menéndez Orenga, Douglas M Salzwedel, Iván Méndez-López · 2024 · Cochrane Database of Systematic Reviews
  21. Comparing the GFR estimation equations using both creatinine and cystatin c to predict the long-term renal outcome in type 2 diabetic nephropathy patients
    Yu Pan, Song Jiang, Dandan Qiu, Jingsong Shi, Minlin Zhou, Yu An, Yongchun Ge, Honglang Xie, Zhihong Liu · 2016 · Journal of Diabetes and its Complications
  22. Early Prediction of Cardiovascular Disease in Kidney Transplant Recipients
    Giancarlo Bilancio, Monia Celano, Vincenzo Cozza, Fabiana Zingone, Giuseppe Palladino, Massimo Círillo · 2017 · Transplantation Proceedings
  23. Survival of Chinese people with type 2 diabetes and diabetic kidney disease: a cohort of 12 -year follow-up
    Zihou Zhao, Lili Huo, Lianying Wang, Lijuan Wang, Zuodi Fu, Yufeng Li, Xiaohong Wu · 2019 · BMC Public Health
  24. Modified arteriosclerosis score predicts the outcomes of diabetic kidney disease
    Yifan Zhang, Qifeng Jiang, Jianteng Xie, Chunfang Qi, Li Sheng, Yanhui Wang, Hokhim Yau, Zujiao Chen, Shaogui Zhang, Qiuling Li et al. · 2021 · BMC Nephrology
  25. Urinary C-megalin as a novel biomarker of progression to microalbuminuria: A cohort study based on the diabetes Distress and Care Registry at Tenri (DDCRT 22)
    Hiroki Nishiwaki, Kakuya Niihata, Maki Kinoshita, Maki Fujimura, Kentaro Kurosawa, Yui Sakuramachi, Kiyoko Takano, Satoshi Matsunaga, Shintaro Okamura, Mako Kitatani et al. · 2022 · Diabetes Research and Clinical Practice
  26. Association of Estimated Glomerular Filtration Rate With Progression of Albuminuria in Individuals With Type 2 Diabetes
    Ko Hanai, Tomomi Mori, Yui Yamamoto, Naoshi Yoshida, Hidekazu Murata, Tetsuya Babazono · 2022 · Diabetes Care
  27. Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem?
    Sivaram Neppala, Jemema Rajan, Eric Yang, Ralph A. DeFronzo · 2024 · Current Cardiology Reports
  28. Cause-Specific Mortality According to Urine Albumin Creatinine Ratio in the General Population
    Tea Skaaby, Lise Lotte N. Husemoen, Tarunveer S. Ahluwalia, Peter R Rossing, Torben Jørgensen, Betina Heinsbæk Thuesen, Charlotta Holm Pisinger, Knud Rasmussen, Allan R Linneberg · 2014 · PLoS ONE
  29. Effects of Simultaneous Iliac Artery Angioplasty on Graft and Patient Survival After Living-Donor Kidney Transplantation
    Duck Jong Han, Young‐Hoon Kim, Young Soo Chung, Youngjin Han, Heungman Jun, Tae‐Won Kwon, Yong‐Pil Cho · 2013 · Transplantation
  30. Cardiovascular prognosis in patients with type 2 diabetes: Contribution of heart and kidney subclinical damage
    Philippe Sosner, Charlotte Hulin-Delmotte, Pierre‐Jean Saulnier, Séverin Cabasson, Elise Gand, Florence Torremocha, Xavier Piguel, A. Miot, R. Maréchaud, Daniel Herpin et al. · 2014 · American Heart Journal
  31. Fluid Overload, Pulse Wave Velocity, and Ratio of Brachial Pre-Ejection Period to Ejection Time in Diabetic and Non-Diabetic Chronic Kidney Disease
    Yi‐Chun Tsai, Yi‐Wen Chiu, Hung‐Tien Kuo, Szu‐Chia Chen, Shang‐Jyh Hwang, Tzu-Hui Chen, Mei‐Chuan Kuo, Hung‐Chun Chen · 2014 · PLoS ONE
  32. Bypass Grafting Versus Percutaneous Intervention—Which Is Better in Multivessel Coronary Disease: Lessons From SYNTAX and Beyond
    Vasim Farooq, Patrick W.J.C. Serruys · 2015 · Progress in Cardiovascular Diseases
  33. Diabetes mellitus as a cause of end-stage renal disease in Europe: signs of improvement
    Jan A.J.G. van den Brand · 2016 · Clinical Kidney Journal
  34. Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease
    Tycho Vuurmans, Lee Er, Alexander A. Sirker, Ognjenka Djurdjev, Gerald J. Simkus, Adeera Levin · 2017 · Coronary Artery Disease
  35. Hypertensive diabetic patients: incidence of cardiovascular and renal outcomes in a historical cohort over 11 years
    Andréa Cristina de Sousa, Thiago Olivera Costa, Thiago Olivera Costa, Fabrício Galdino Magalhães, Marcos Paulo Marinho Montelo, Weimar Kunz Sebba Barroso, Paulo César Brandão Veiga Jardim, Ana Luíza Lima Sousa · 2017 · Diabetology & Metabolic Syndrome
  36. Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney disease
    Oshini Shivakumar, Naveed A. Sattar, David Collins. Wheeler · 2020 · Nephrology Dialysis Transplantation
  37. Associations between untraditional risk factors, pneumonia/lung cancer, and hospital fatality among hypertensive men in Guangzhou downtown
    Yuechun Shen, Yuelin Chen, Zheng Huang, Junyao Huang, Xinchun Li, Zuojun Tian, Jun Li · 2020 · Scientific Reports
  38. Association of overhydration and serum pigment epithelium-derived factor with CKD progression in diabetic kidney disease: A prospective cohort study
    Allen Yan Lun Liu, Sharon Li Ting Pek, Serena KM Low, Angela Mei Chung Moh, Keven Ang, Wern Ee Tang, Ziliang Lim, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim · 2021 · Diabetes Research and Clinical Practice
  39. A long-term nationwide study on chronic kidney disease-related mortality in Italy: trends and associated comorbidity
    Simone Maria Navarra, Anna Solini, Marco Giorgio Baroni, Luisa Frova, Enrico Grande · 2021 · Journal of Nephrology
  40. 24-h Glycaemic profiles in peritoneal dialysis patients and non-dialysis controls with advanced kidney disease
    Jennifer K. Williams, Mark Gilchrist, William David Strain, Donald J. Fraser, Angela C. Shore · 2021 · Peritoneal Dialysis International
  41. Comparison of renal arterial resistive index in type 2 diabetic nephropathy stage 0-4
    Sharareh Sanei Sistani, Ali Alidadi, Alireza Ansari‐Moghaddam, Fatemeh Mohamadnezhad, Bahareh Heshmat Ghahderijani · 2019 · European Journal of Translational Myology
  42. Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study
    Renal Insufficiency Cardiovascular Events (RIACE) Study Group, Giuseppe Penno, Anna Solini, Giacomo Zoppini, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Luigi Cavalot, Gabriella Gruden, Olga Lamacchia et al. · 2015 · Acta Diabetologica
  43. Five‐year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention
    Agam D. Patel, Mohammed Ibrahim, Rajesh V. Swaminathan, Irfan U. Minhas, Luke K. Kim, Prashanth Venkatesh, Dmitriy N. Feldman, Robert M. Minutello, Geoffrey W. Bergman, Shing Chiu Wong et al. · 2016 · Catheterization and Cardiovascular Interventions
  44. Mild to moderate chronic kidney disease and functional disability in community-dwelling older adults. The Cardiovascular risk profile in Renal patients of the Italian Health Examination Survey (CARHES) study
    Giovanni Viscogliosi, Luca De Nicola, Diego Vanuzzo, Simona Giampaoli, Luigi Palmieri, Chiara Donfrancesco · 2018 · Archives of Gerontology and Geriatrics
  45. Comparison of the Effects of Laparoscopic and Open Surgery on Postoperative Acute Kidney Injury in Patients with Colorectal Cancer: Propensity Score Analysis
    Ji‐Hoon Sim, Sa-Jin Kang, Ji‐Yeon Bang, Jun‐Gol Song · 2021 · Journal of Clinical Medicine
  46. Polyphenols mediated attenuation of diabetes associated cardiovascular complications: A comprehensive review
    Navdeep Kour, Gulshan Bhagat, Simran Singh, Sandip Singh Bhatti, Saroj Arora, Balbir Singh, Astha Bhatia · 2023 · Journal of Diabetes & Metabolic Disorders
  47. Framework of Guidelines for Management of CKD in Asia
    Carol A. Pollock, Juyoung Moon, Le Pham Ngoc Ha, Pongsathorn Gojaseni, Chen Hua Ching, Lynn Gomez, Tak Mao Chan, Ming‐Ju Wu, See Cheng Yeo, Pringgodigdo Nugroho et al. · 2023 · Kidney International Reports
  48. Within and post-trial effects of an intensive lifestyle intervention on kidney disease in adults with overweight or obesity and type 2 diabetes mellitus: a secondary analysis of the Look AHEAD clinical trial
    William C. Knowler, Haiying Chen, Judy L. Bahnson, Steven E. Kahn, Cora Elizabeth Lewis, David M. Nathan, Robert G. Nelson, Scott J. Pilla, John P. Bantle · 2024 · BMJ Open Diabetes Research & Care
  49. Hyperactivity and Pro-inflammatory Functions of Platelets in Diabetes
    Jordan Greaves, Giordano Pula · 2025 · Frontiers in Bioscience-Landmark
  50. Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey ( NHANES ) 2003–2018
    Xiaoxia Pang, Wenchao Dan, Lan Lin, Huimei Li, Xiang-rong Rao, Shen Li · 2025 · Diabetes Obesity and Metabolism
  51. Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: What Does the Cardiologist Need to Know?
    Martin Berger, Nikolaus Marx, Katharina Marx-Schütt · 2025 · European Cardiology Review
  52. Diabetic Kidney Disease in Type 2 Diabetes: A Comprehensive Review of Epidemiology, Pathophysiology, and Therapeutic Advances
    A. Uma, Shanmugapriyan Sivaraman, Rajesh Manoharan, Panneerselvam Periasamy · 2025 · Journal of Pharmacy And Bioallied Sciences
  53. The nonsteroidal MR antagonist finerenone reverses Western diet-induced kidney disease by regulating mitochondrial and lipid metabolism and inflammation
    Komuraiah Myakala, Xiaoxin X. Wang, Nataliia V. Shults, Eleni P. Hughes, Patrícia de Carvalho Ribeiro, Rozhin Penjweini, Katie A. Link, Keely Barton, Ewa Krawczyk, Cheryl Clarkson Paredes et al. · 2025 · American Journal of Physiology-Renal Physiology
  54. Rewriting Diabetes Therapy: How Incretin Modulation is Transforming Cardiovascular and Renal Outcomes
    José Pablo Miramontes‐González, Álvaro Rodrigo-Alaíz, Miriam Gabella-Martín, David González Calle, Juana Carretero-Gómez, Luís Corral-Gudino · 2026 · Diabetes Therapy
  55. Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy?
    Stavroula Veneti, Κωνσταντίνος Τζιόμαλος · 2020 · World Journal of Diabetes
  56. Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    Huaxing Huang, Lianglan Shen, Haiyan Huang, Lihua Zhao, Feng Xu, Dongmei Zhang, Xiulin Zhang, Tong Chen, Xueqin Wang, Yan Xie et al. · 2021 · Diabetes & Metabolism Journal
  57. Circulating TNF Receptor 2 is Closely Associated with the Kidney Function in Non-Diabetic Japanese Subjects
    Tomoyuki Kurashina, Shoichiro Nagasaka, Naoya Watanabe, Daisuke Yabe, Noriko Sugi, Kazuko Nin, Masaya Hosokawa, Yoshio Nomura, Mitsuo Fukushima, Yoshikatsu Nakai et al. · 2014 · Journal of Atherosclerosis and Thrombosis
  58. Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors from a registry-based cohort
    María Téllez-Plaza, Domingo Orozco‐Beltrán, Vicente Francisco Gil-Guillén, Salvador Pita‐Fernández, Jorge Navarro-Pérez, Vicente Pallarés‐Carratalá, Francisco Valls, Antonio García Fernández, Ana María Perez-Navarro, Carlos Sanchís et al. · 2016 · Journal of Hypertension
  59. Riesgo de mortalidad asociado a enfermedad renal crónica en pacientes con diabetes tipo 2 durante un seguimiento de 13 años
    José Antonio Gimeno-Orna, Yolanda Blasco Lamarca, Belén Campos-Gutiérrez, Edmundo Molinero-Herguedas, Luis Miguel Lou-Arnal, Blanca García-García · 2015 · Nefrología
  60. Individual and Combined Relationship between Reduced eGFR and/or Increased Urinary Albumin Excretion Rate with Mortality Risk among Insulin-Treated Patients with Type 2 Diabetes in Routine Practice
    Uchenna Anyanwagu, Richard Donnelly, ISKANDAR RAUF IDRIS · 2018 · Kidney Diseases
  61. The relationship between urinary albumin excretion, cardiovascular outcomes and total mortality among a large cohort of insulin-treated patients with type 2 diabetes in routine primary care practices
    Uchenna Anyanwagu, Richard Donnelly, ISKANDAR RAUF IDRIS · 2018 · Nephrology Dialysis Transplantation
  62. Association of abdominal aortic calcification estimated by plain radiography with outcomes in haemodialysis patients: A 6‐year follow‐up study
    Xuying Zhu, Hong Cai, Minxia Zhu, Yaping Zhan, Miaolin Che, Xinghui Lin, Weiming Zhang, Zhaohui Ni · 2019 · Nephrology
  63. Projection of the health and economic impacts of Chronic kidney disease in the Chilean population
    Magdalena Walbaum, Shaun Scholes, Rubén Rojas, Jennifer Susan Mindell, Elena Pizzo · 2021 · PLoS ONE
  64. Low GFR amplifies the association between coronary three-vessel disease and all-cause mortality
    Pamela Angela Piscitelli, Maria Maddalena D’Errico, Antonio Mirijello, Mariateresa Santoliquido, Mauro Pellegrino Salvatori, Carlo Vigna, Nicola Marchese, Gianluigi Vendemiale, Massimiliano Copetti, Roberto Pontremoli et al. · 2021 · Nutrition Metabolism and Cardiovascular Diseases
  65. Impaired fasting blood glucose is associated with incident albuminuria: Data from a Chinese community-based cohort
    Yimeng Jiang, Jia Jia, Jianping Li, Yong Huo, Fangfang Fan, Yan Zhang · 2022 · Journal of Diabetes and its Complications
  66. Australian general practitioners’ perspectives on integrating specialist diabetes care with primary care: qualitative study
    Rachael Taylor, Shamasunder Acharya, Martha Parsons, Ushank Ranasinghe, Kerry Fleming, Melissa L. Harris, Deniz Kuzulugil, Julie Byles, Annalise Philcox, Meredith Tavener et al. · 2023 · BMC Health Services Research
  67. Complicaciones microvasculares de la diabetes
    Belén Pérez‐Pevida, María Llavero, Javier Gargallo, Javier Escalada · 2016 · Medicine - Programa de Formación Médica Continuada Acreditado
  68. Is Change in Albuminuria a Surrogate Marker for Cardiovascular and Renal Outcomes in Type 1 Diabetes?
    Bradley S. Dixon · 2016 · Clinical Journal of the American Society of Nephrology
  69. Impaired SIRT 1 activity leads to diminution in glomerular endowment without accelerating age‐associated GFR decline
    Ashley R. Bellin, Yanling Zhang, Kerri Thai, Norman D. Rosenblum, Luise A. Cullen‐McEwen, John F. Bertram, Richard E. Gilbert · 2019 · Physiological Reports
  70. Differential metabolomic signatures of declining renal function in Types 1 and 2 diabetes
    Maria Laura Manca, Anna Solini, Jani K. Haukka, Niina Sandholm, Carol M. Forsblom, Per‐Henrik Groop, Ele Ferrannini · 2020 · Nephrology Dialysis Transplantation
  71. Digging Deeper: Hidden Messages Beyond the Overall Prevalence of Diabetic Kidney Disease
    Helen Tam‐Tham, David J.T. Campbell, Brenda R. Hemmelgarn · 2016 · American Journal of Kidney Diseases
  72. Direct Evidence of Endothelial Dysfunction and Glycocalyx Loss in Dermal Biopsies of Patients With Chronic Kidney Disease and Their Association With Markers of Volume Overload
    Josephine Koch, Ryanne S. Hijmans, Manuela Ossa Builes, Wendy Dam, Robert A. Pol, Stephan J. L. Bakker, Hendri H. Pas, Casper F. M. Franssen, Jacob van den Born · 2021 · Frontiers in Cell and Developmental Biology
  73. A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD
    Ajay K. Singh, Stefan D. Anker, Bertram Pitt, Peter R Rossing, Luis Miguel Ruilope, Christiane Ahlers, Youssef M.K. Farag, Marc Lambelet, MEIKE DANIELA BRINKER, Katja Rohwedder et al. · 2025 · Kidney International Reports
  74. Evaluation of kidney function among people living with HIV initiating antiretroviral therapy in Zambia
    Jake M. Pry, Michael J. Vinikoor, Carolyn Bolton‐Moore, Monika Roy, Aaloke Mody, Izukanji T Sikazwe, Anjali Sharma, Belinda Chihota, Miquel Duran‐Frigola, Harriet E. Daultrey et al. · 2022 · PLOS Global Public Health
  75. Cystatin C–based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study
    Jinlan Liao, Fei Xiao, Liuqiao Yang, Yanling Wei, Congying Song, Jing Li, Sike Yu, Yueqi Lu, Jingwen Zhang, Liang Dai et al. · 2023 · Clinical Kidney Journal
  76. Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 Diabetes
    Daryl J. Fediuk, Donal N. Gorman, Stephanie‐An Stoddard, Yizhong Zhang, Adam G. Ogden, Jennifer A. Winton, Aditi R. Saxena · 2023 · The Journal of Clinical Pharmacology
  77. Association of Chronic Kidney Disease with Cardiovascular Disease in Cancer Patients: A Cross-Sectional Study
    An‐Bang Liu, Dan Zhang, Tingting Meng, Yu Zhang, Peng Tian, Jianlin Chen, Yan Zheng, Guohai Su · 2023 · Cardiorenal Medicine
  78. Impact of initial dialysis modality on the survival of patients with ESRD: a propensity-score-matched study
    Li Liu, Jie Pang, Juan Xu, Linna Liu, Man-yu Liao, Qing-xiu Huang, Yanlin Li · 2023 · BMC Nephrology
  79. A practical evidence-based approach to management of type 2 diabetes in children and young people (CYP): UK consensus
    Billy White, S M Ng, Juliana Chizo Agwu, Timothy Geoffrey Barrett, Nicola Birchmore, Melanie Kershaw, J. Drew, Fotini K. Kavvoura, James Law, Christopher Moudiotis et al. · 2024 · BMC Medicine
  80. The early diagnosis and treatment of chronic renal insufficiency
    Kai M. Hahn, Frank M. Strutz · 2024 · Deutsches Ärzteblatt international
  81. Does body mass index influence the decline of glomerular filtration rate in diabetic type 2 patients with diabetic nephropathy in a developing country?
    Y. Bentata, H. Latrech, R. Abouqal · 2014 · Renal Failure
  82. Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetes
    Joshua I. Barzilay, Barry R. Davis, Alokananda Ghosh, Sara Pressel, Mahboob Rahman, Paula T. Einhorn, William C. Cushman, Paul Kieran Whelton, Jackson T. Wright · 2018 · Journal of Diabetes and its Complications
  83. Ten-year risk prediction models of complications and mortality of Chinese patients with diabetes mellitus in primary care in Hong Kong: a study protocol
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Colman Siu Cheung Fung, Ruby Lai Ping Kwok, David Vai Kiong Chao, King Hong Chan, Eric Ming‐Tung Hui, Wendy Wing Sze Tsui, K. C. B. Tan et al. · 2018 · BMJ Open
  84. CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle
    Guntram Schernthaner, Christoph Wanner, Dubravka Jurišić‐Eržen, Cristian Guja, Janusz Gumprecht, Iwona Renata Jarek-Martynowa, Avraham Karasik, Nebojsa M. Lalic, Boris Mankovsky, Martin Prázný et al. · 2019 · Diabetes Research and Clinical Practice
  85. Gender Disparity in the Risk of Hypertension in Subjects With Major Depressive Disorder
    Wei-Tsung Kao, Chen‐Lin Chang, Chi‐Hung Lin, Shang-Liang Wu, Shang-Lun Lin, For‐Wey Lung · 2019 · Frontiers in Psychiatry
  86. Association of Nuclear Factor Erythroid-2-Related Actor 2 Gene Polymorphisms with Diabetic Nephropathy in Chinese Patients
    Jiancheng Wang, Meiling Yu, Jianrong Chen, Lingyan Zhu, Jianying Liu, Jixiong Xu · 2021 · International Journal of General Medicine
  87. Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity
    Natalie May Zahr, Kilian M. Pohl, Allison J. Kwong, Edith V. Sullivan, Adolf Pfefferbaum · 2021 · International Journal of Molecular Sciences
  88. Constipation and diabetic kidney disease: The Fukuoka Diabetes Registry
    Toshiaki Ohkuma, Masanori Iwase, Hiroki Fujii, Hitoshi Ide, Yuji Komorita, Masahito Yoshinari, Yutaro Oku, Taiki Higashi, Ayaka Oshiro, Udai Nakamura et al. · 2021 · Clinical and Experimental Nephrology
  89. Global Epidemiology, Health Outcomes, and Treatment Options for Patients With Type 2 Diabetes and Kidney Failure
    Jessica Phillips, Jenny H. C. Chen, Esther M. M. Ooi, Janelle Prunster, Wai H. Lim · 2021 · Frontiers in Clinical Diabetes and Healthcare
  90. Interacción entre el estadio de la enfermedad renal crónica y la diabetes mellitus como factores asociados con mortalidad en pacientes con enfermedad renal crónica: un estudio de cohortes externas
    Laura Elisa Villegas Sierra, Melisa Buriticá Agudelo, Carlos Enrique Yepes Delgado, Yanett Marcela Montoya Jaramillo, Fabian Alberto Jaimes · 2021 · Nefrología
  91. Predictors of clinical outcome after rotational atherectomy-facilitated percutaneous coronary intervention in hemodialysis patients
    Haojian Dong, Daisuke Hachinohe, Zhiqiang Nie, Yoshifumi Kashima, Guang Li, Takuya Haraguchi, Hidemasa Shitan, Tomohiko Watanabe, Yutaka Tadano, Umihiko Kaneko et al. · 2021 · Annals of Palliative Medicine
  92. Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology
    Simke W. Waijer, Michele Provenzano, Skander Mulder, Peter R Rossing, Frederik Persson, Vlado Perkovic, Hiddo J.L. Heerspink · 2022 · Diabetes Obesity and Metabolism
  93. Ameliorative Effects of Annona muricata Leaf Ethanol Extract on Renal Morphology of Alloxan-Induced Mice
    Supri Irianti Handayani, Mutiara Intan Permata Sari, Meilania Saraswati Sardjana, Kusmardi Kusmardi, Siti Nurbaya, Rosmalena Rosmalena, Ernawati Sinaga, Vivitri Dewi Prasasty · 2022 · Applied Sciences
  94. Poor adherence to clinical practice guidelines: A call to action for increased albuminuria testing in patients with type 2 diabetes
    Todd E Williamson, Evelyn Gomez-Espinosa, Fiona Anne Stewart, Bonnie B. Dean, Rakesh Singh, Jingsong Cui, Sheldon Xiaodong Kong · 2023 · Journal of Diabetes and its Complications
  95. Burden of Diabetes Related Complications Among Hypertensive and Non Hypertensive Diabetics: A Comparative Study
    Krishna Mohan Surapaneni · 2015 · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
  96. Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease
    Arianne van Koppen, Diana A. Papazova, Nynke R. Oosterhuis, Hendrik Gremmels, Rachel H. Giles, Joost Ougust Fledderus, Jaap A. Joles, Marianne Christina Verhaar · 2015 · Stem Cell Research & Therapy
  97. The Rationale/Design of the Guimarães/Vizela Study: A Multimodal Population-Based Cohort Study to Determine Global Cardiovascular Risk and Disease
    Pedro Cunha, Jorge Cotter, Pedro Oliveira, Isabel Vila, Nuno Sousa · 2014 · Journal of Investigative Medicine
  98. Do patients with chronic kidney disease get optimal cardiovascular risk reduction?
    Mark K. Elliott, Jennifer A. McCaughan, Damian G. Fogarty · 2014 · Current Opinion in Nephrology & Hypertension
  99. Progress in risk prediction for people with chronic kidney disease
    Maarten W. Taal · 2014 · Current Opinion in Nephrology & Hypertension
  100. Osmotic indices and kidney concentrating activity: population-based data on correlates and prognostic power
    Massimo Círillo, Giancarlo Bilancio, Cinzia Lombardi, Pierpaolo Cavallo, Oscar Terradura-Vagnarelli, Alberto Zanchetti, Martino W. Laurenzi · 2016 · Nephrology Dialysis Transplantation